2A41

ICD-11 MMS 2026-01

Atypical chronic myeloid leukaemia, BCR-ABL1-negative

Description

A myelodysplastic/myeloproliferative neoplasm characterised by the principal involvement of the neutrophil series with leukocytosis with circulating immature myeloid cells, fewer than 20 percent blasts in the bone marrow and blood, and severe dysgranulopoiesis. The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL1 fusion gene.

Index terms

  • Atypical chronic myeloid leukaemia, BCR-ABL1-negative
  • Atypical chronic myeloid leukaemia, BCR-ABL-negative without mention of remission
  • atypical chronic myeloid leukaemia
Show allHide
  • subacute monocytic leukaemia
  • subacute monocytic leukaemia without mention of remission
  • subacute myelogenous leukaemia
  • subacute myeloid leukaemia
  • subacute myelosis
  • Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Sibling codes

  • 2A40 – Chronic myelomonocytic leukaemia
  • 2A42 – Juvenile myelomonocytic leukaemia
  • 2A43 – Refractory anaemia with ring sideroblasts associated with marked thrombocytosis
  • 2A44 – Myeloproliferative and myelodysplastic disease, unclassifiable
  • 2A4Y – Other specified myelodysplastic and myeloproliferative neoplasms
  • 2A4Z – Myelodysplastic and myeloproliferative neoplasms, unspecified

Foundation entity

Atypical chronic myeloid leukaemia, BCR-ABL1-negative – http://id.who.int/icd/entity/331838766

Allowed postcoordination axes

Part of: 02: Neoplasms